New Swedish Leukaemia Drug

A new Swedish medicine prevents leukaemia sufferers from having relapses.

Previously patients with the disease had to rely on painful bone marrow transplants.

Of those that took the new medicine 40 percent recovered compared to 26 percent who had no treatment at all, report Swedish newspaper Dagens Nyheter.

Two hundred and fifty people are affected by the acute form of the illness every year in Sweden.

The medicine has been approved by the Swedish Medical Products Agency but must now wait to be certified by the European Commission.

Our journalism is based on credibility and impartiality. Swedish Radio is independent and not affiliated to any political, religious, financial, public or private interests.
Du hittar dina sparade ljud i menyn under Min lista